The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Open accessAbstract
Metastasis, the dissemination and growth of neoplastic cells in an organ distinct from that in which they originated, is the most common cause of death in cancer patients. This is particularly true for pancreatic cancers, where most patients are diagnosed with metastatic disease and few show a sustained response to chemotherapy or radiation therapy. Whether the dismal prognosis of patients with pancreatic cancer compared to patients with other types of cancer is a result of late diagnosis or early dissemination of disease to distant organs is not known. Here we rely on data generated by sequencing the genomes of seven pancreatic cancer metastases to evaluate the clonal relationships among primary and metastatic cancers. We find that clonal populations that give rise to distant metastases are represented within the primary carcinoma, but these clones are genetically evolved from the original parental, non-metastatic clone. Thus, genetic heterogeneity of metastases reflects that within the primary carcinoma. A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell. At least five more years are required for the acquisition of metastatic ability and patients die an average of two years thereafter. These data provide novel insights into the genetic features underlying pancreatic cancer progression and define a broad time window of opportunity for early detection to prevent deaths from metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“modeling studies performed on the mutational data have estimated that the timeline of multistep progression to invasive neoplasia in the pancreas likely spans multiple years and provides a theoretically wide window of opportunity for early detection27.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [27]
In the citing paper
“Pancreatic tumours are highly heterogeneous, both within and between individuals.66,67”
From Early detection of pancreatic cancer (2020) · cites this paper as [67]
In the citing paper
“It is now appreciated that most clinically relevant solid tumors are highly heterogeneous at the phenotypic, physiologic, and genomic levels (13–15) and that they continue to evolve over time.”
From Radiomics: Images Are More than Pictures, They Are Data (2016) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Self-citationCore Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationMetastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2622 · Cited by 2,716
Isaacson, P. G., Doǧan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,913
Comparative lesion sequencing provides insights into tumor evolution
Jones, S., Chen, W.-D. D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Tibor Antal, A., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 827
Self-citationAdvanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791
Signatures of mutation and selection in the cancer genome
Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707
Self-citationMaitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,006
Hu, W., Fang, L., Hua, W., & Gou, S. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.07.002 · Cited by 70
BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer
Chiou, S., Risca, V. I., Wang, G. X., Yang, D., Grüner, B. M., Kathiria, A. S., Ma, R. K., Vaka, D., Chu, P., Kozak, M. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0250 · Cited by 70
Glioblastoma: To Target the Tumor Cell or the Microenvironment?
Vleeschouwer, S. D., & Bergers, G. (2017) · Codon Publications eBooks · doi:10.15586/codon.glioblastoma.2017.ch16 · Cited by 73
Pancreatic Cancer Patient Survival Correlates with DNA Methylation of Pancreas Development Genes
Thompson, M. J., Rubbi, L., Dawson, D. W., Donahue, T. R., & Pellegrini, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128814 · Cited by 70
Lynch, S. M., Major, J. M., Cawthon, R., Weinstein, S. J., Virtamo, J. R. K., Qing Lan, B., Rothman, N., Albanes, D., & Stolzenberg‐Solomon, R. Z. (2013) · International Journal of Cancer · doi:10.1002/ijc.28272 · Cited by 69
Pancreatic cancer–associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation
Gore, A. J., McElyea, S. D., Palam, L. R., Craven, K. E., & Korc, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71526 · Cited by 70
Potential Targets for Pancreatic Cancer Immunotherapeutics
Dodson, L. F., Hawkins, W. G., & Goedegebuure, P. S. (2011) · Immunotherapy · doi:10.2217/imt.11.10 · Cited by 70
Aspirin Use and Reduced Risk of Pancreatic Cancer
Risch, H. A., Lu, L., Streicher, S. A., Wang, J., Zhang, W., Ni, Q., Kidd, M. S., Yu, H., & Gao, Y.-T. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0508 · Cited by 71
Genetics and Genetic Testing in Pancreatic Cancer
Whitcomb, D. C., Shelton, C. A., & Brand, R. E. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.057 · Cited by 69
The challenges associated with molecular targeted therapies for glioblastoma
Jue, T. R., & McDonald, K. L. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2080-6 · Cited by 68
Onidani, K., Shoji, H., Kakizaki, T., Yoshimoto, S., Okaya, S., Miura, N., Sekikawa, S., Furuta, K., Lim, C. T., Shibahara, T., et al. (2019) · Cancer Science · doi:10.1111/cas.14092 · Cited by 69
Imamura, T., Komatsu, S., Ichikawa, D., Kawaguchi, T., Miyamae, M., Okajima, W., Ohashi, T., Arita, T., Konishi, H., Shiozaki, A., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i25.5627 · Cited by 73
Mitchell, K. G., Farooqi, A. S., Ludmir, E. B., Corsini, E. M., Zhang, J., Sepesi, B., Vaporciyan, A. A., Swisher, S. G., Heymach, J. V., Zhang, J., et al. (2019) · Clinical Lung Cancer · doi:10.1016/j.cllc.2019.07.007 · Cited by 68
Thu, K. L., Radulovich, N., Becker‐Santos, D. D., Pikor, L. A., Pusic, A., Lockwood, W. W., Lam, W. L., & Tsao, M. (2013) · Oncogene · doi:10.1038/onc.2012.595 · Cited by 77
Ishiwata, T., Matsuda, Y., Yamamoto, T., Uchida, E., Korc, M., & Naito, Z. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.020 · Cited by 67
New insights into pancreatic cancer stem cells
Rao, C. V. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i3.547 · Cited by 68
Precision Oncology: Between Vaguely Right and Precisely Wrong
Brock, A., & Huang, S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0448 · Cited by 71
Matsuda, Y. (2019) · Pathology International · doi:10.1111/pin.12837 · Cited by 61
Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach
Blanco, M., Concha, Á., Figueroa, A., Garrido, F., & Valladares‐Ayerbes, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160613610 · Cited by 67
The evolution of the unstable cancer genome
Burrell, R. A., & Swanton, C. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.011 · Cited by 66
Pancreatic Cancer Metastasis: Are we being Pre-EMTed?
Das, S., & Batra, S. K. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666141211115234 · Cited by 65
Improving outcomes of patients with pancreatic cancer
Dreyer, S. B., Beer, P. A., Hingorani, S. R., & Biankin, A. V. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01019-9 · Cited by 71
Circulating tumor cells in the diagnosis and management of pancreatic cancer
Cen, P., Ni, X., Yang, J., Graham, D. Y., & Li, M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.007 · Cited by 65
HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer
Burkhart, R. A., Pineda, D. M., Chand, S. N., Romeo, C., Londin, E. R., Karoly, E. D., Cozzitorto, J. A., Rigoutsos, I., Yeo, C. J., Brody, J. R., et al. (2013) · RNA Biology · doi:10.4161/rna.25274 · Cited by 64
Brodsky, A. S., Fischer, A. K., Miller, D., Vang, S., MacLaughlan, S. D., Wu, H.-T., Yu, J., Steinhoff, M. M., Collins, C. C., Smith, P. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094476 · Cited by 65
Clinical and pathologic features of familial pancreatic cancer
Humphris, J. L., Johns, A. L., Simpson, S. H., Cowley, M. J., Pajic, M., Chang, D. K.-F., Nagrial, A. M., Chin, V. T., Chantrill, L. A., Pinese, M., et al. (2014) · Cancer · doi:10.1002/cncr.28863 · Cited by 65
Molecular Events in the Natural History of Pancreatic Cancer
Oldfield, L. E., Connor, A. A., & Gallinger, S. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.04.005 · Cited by 65
Current Approaches to Pancreatic Cancer Screening
Chhoda, A., Lu, L., Clerkin, B. M., Risch, H. A., & Farrell, J. J. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.09.013 · Cited by 64
Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ Discovery
Brancaccio, M., Natale, F., Falco, G., & Angrisano, T. (2019) · Genes · doi:10.3390/genes11010014 · Cited by 65
Elena, J. W., Travis, L. B., Simonds, N. I., Ambrosone, C. B., Ballard-Barbash, R. R., Bhatia, R., Cerhan, J. R., Hartge, P. A., Heist, R. S., Kushi, L. H., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs473 · Cited by 65
Palamaris, K., Felekouras, E. S., & Sakellariou, S. (2021) · Cancers · doi:10.3390/cancers13215532 · Cited by 70
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits
Maneshi, P., Mason, J. E., Dongre, M., & Öhlund, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.787485 · Cited by 68
Evan, T., Wang, V. M.-Y., & Behrens, A. (2022) · Oncogene · doi:10.1038/s41388-022-02448-x · Cited by 66
Update on pediatric cancer predisposition syndromes
Schiffman, J. D., Geller, J. I., Mundt, E., Means, A. R., Means, L., & Means, V. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24555 · Cited by 64
Emerging roles of the tumor-associated stroma in promoting tumor metastasis
Horimoto, Y., Polanska, U. M., Takahashi, Y., & Orimo, A. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20631 · Cited by 65
Mohammed, A., Janakiram, N. B., Madka, V., Ritchie, R. L., Brewer, M. F., Biddick, L., Patlolla, J. M. R., Sadeghi, M., Lightfoot, S. A., Steele, V. E., et al. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0176 · Cited by 64
The Impact of Obesity on Gallstone Disease, Acute Pancreatitis, and Pancreatic Cancer
Cruz‐Monserrate, Z., Conwell, D. L., & Krishna, S. G. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.07.010 · Cited by 66
Hsieh, C., Shyr, Y., Liao, W., Chen, T.-H., Wang, S.-E., Lu, P.-C., Lin, P.-Y., Chen, Y.-B., Mao, W.-Y., Han, H.-Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13845 · Cited by 65
Neoplasms of the Exocrine Pancreas
Wolff, R. A., Crane, C. H., Li, D., Evans, D. B., Maitra, A., & Tsai, S. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm094 · Cited by 64
Ischenko, I., Petrenko, O., & Hayman, M. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319911111 · Cited by 62
Ma, Y., Chai, N., Jiang, Q., Chang, Z., Chai, Y., Li, X., Sun, H., Hou, J., & Linghu, E. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105071 · Cited by 63
Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy
Huang, F., Santinon, F., González, R. E. F., & Rincon, S. V. D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.756001 · Cited by 66
Electroporation and Immunotherapy—Unleashing the Abscopal Effect
Justesen, T. F., Orhan, A., Raskov, H., Nolsøe, C., & Gögenür, I. (2022) · Cancers · doi:10.3390/cancers14122876 · Cited by 67
Potential side effects to GLP-1 agonists: understanding their safety and tolerability
Consoli, A., & Formoso, G. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.987122 · Cited by 65
Epigenetic stochasticity, nuclear structure and cancer: the implications for medicine
Feinberg, A. P. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12224 · Cited by 63
Idikio, H. (2011) · Journal of Cancer · doi:10.7150/jca.2.107 · Cited by 64
Wu, L. L., Zhang, X., Zhao, Z., Wang, L., Li, B., Li, G., Dean, M. C., Yu, Q., Wang, Y., Lin, X., et al. (2015) · GigaScience · doi:10.1186/s13742-015-0091-4 · Cited by 59
Reprogramming of human cancer cells to pluripotency for models of cancer progression
Kim, J., & Zaret, K. S. (2015) · The EMBO Journal · doi:10.15252/embj.201490736 · Cited by 62
Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior
Şahin, İ. H., Elias, H. K., Chou, J. F., Capanu, M., & O'Reilly, E. M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4679-9 · Cited by 64
An in vivo multiplexed small-molecule screening platform
Grüner, B. M., Schulze, C. J., Yang, D., Ogasawara, D., Dix, M. M., Rogers, Z. N., Chuang, C.-H., McFarland, C. D., Chiou, S.-H., Brown, J. M., et al. (2016) · Nature Methods · doi:10.1038/nmeth.3992 · Cited by 62
Qiao, Y., Quinlan, A. R., Jazaeri, A. A., Verhaak, R. G. W., Wheeler, D. A., & Marth, G. (2014) · Genome biology · doi:10.1186/preaccept-1691129011290725 · Cited by 61
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases
Romei, C., Ciampi, R., Casella, F., Tacito, A., Torregrossa, L., Ugolini, C., Basolo, F., Materazzi, G., Vitti, P., & Elisei, R. (2018) · Oncotarget · doi:10.18632/oncotarget.23986 · Cited by 62
Barnes, C. A., Chavez, M. I., Tsai, S., Aldakkak, M., George, B., Ritch, P. S., Dua, K. S., Clarke, C. N., Tolat, P. P., Hagen, C. E., et al. (2019) · Surgery · doi:10.1016/j.surg.2019.05.010 · Cited by 62
Klatte, D. C. F., Wallace, M. B., Löhr, M. J., Bruno, M. J., & van Leerdam, M. E. (2022) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2021.101783 · Cited by 68
Glioma Stem Cells: Novel Data Obtained by Single-Cell Sequencing
Gisina, A. M., Kholodenko, I. V., Kim, Y. S., Abakumov, M. A., Lupatov, A. Y., & Yarygin, K. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214224 · Cited by 68
Carbone, C., Piro, G., Fassan, M., Tamburrino, A., Mina, M. M., Zanotto, M., Chiao, P. J., Bassi, C., Scarpa, A., Tortora, G., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2635 · Cited by 62
S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer
Plaza, S. D., Padilla, L., Adán, J., Masa, M., Martinez, J. M., Roque, L., Coll, T., Hervás, R., Calvis, C., Messeguer, R., et al. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.7 · Cited by 63
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor
Valetti, S., Maione, F., Mura, S., Stella, B., Desmaële, D., Noiray, M., Vergnaud, J., Vauthier, C., Cattel, L., Giraudo, E., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.039 · Cited by 67
Chang, D. K.-F., Grimmond, S. M., & Biankin, A. V. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.001 · Cited by 62
Kim, M., Zhong, Y., Yachida, S., Rajeshkumar, N. V., Abel, M. L., Marimuthu, A., Mudgal, K. S., Hruban, R. H., Poling, J., Tyner, J. W., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.038547 · Cited by 61
Self-citationMET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)
Casadevall, D., Gimeno, J., Clavé, S., Taus, Á., Pijuán, L., Arumí, M., Lorenzo, M., Menéndez, S., Cañadas, I., Albanell, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3976 · Cited by 64
Lee, J., Snyder, E. R., Liu, Y., Gu, X., Wang, J., Flowers, B. M., Kim, Y. J., Park, S., Szot, G. L., Hruban, R. H., et al. (2017) · Nature Communications · doi:10.1038/ncomms14686 · Cited by 64
Self-citationHusain, K. M., Centeno, B. A., Coppola, D., Trevino, J. G., Sebti, S. M., & Malafa, M. P. (2017) · Oncotarget · doi:10.18632/oncotarget.15767 · Cited by 62
Zhang, H., Yu, Y., Zhou, L., Ma, J., Tang, K., Xu, P., Ji, T., Liang, X., Lv, J., Dong, W., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0574 · Cited by 63
Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype
Swayden, M., Iovanna, J., & Soubeyran, P. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e01055 · Cited by 63
Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis
Natale, F., Vivo, M., Falco, G., & Angrisano, T. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0728-8 · Cited by 64
Molecular prescreening to select patient population in early clinical trials
Rodon, J. A., Saura, C., Dienstmann, R., Vivancos, A. P., y Cajal, S. R., Baselga, J. M., & Tabernero, J. M. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.48 · Cited by 62
Furukawa, K., Kawamoto, K., Eguchi, H., Tanemura, M., Tanida, T., Tomimaru, Y., Akita, H., Hama, N., Wada, H., Kobayashi, S., et al. (2014) · Pancreas · doi:10.1097/mpa.0000000000000205 · Cited by 61
Surgical Management of Pancreatic Cancer—Pancreaticoduodenectomy
Donahue, T. R., & Reber, H. A. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.009 · Cited by 61
Ogawa, H., Nagano, H., Konno, M., Eguchi, H., Koseki, J., Kawamoto, K., Nishida, N., Colvin, H. S., Tomokuni, A., Tomimaru, Y., et al. (2015) · Molecular and Clinical Oncology · doi:10.3892/mco.2015.490 · Cited by 61
Cefalu, W. T., Buse, J. B., Prato, S. D., Home, P., LeRoith, D., Nauck, M. A., Raz, I., Rosenstock, J., & Riddle, M. C. (2014) · Diabetes Care · doi:10.2337/dc14-1395 · Cited by 62
The role of tandem duplicator phenotype in tumour evolution in high‐grade serous ovarian cancer
Ng, C. K. Y., Cooke, S. L., Howe, K., Newman, S., Xian, J., Temple, J., Batty, E. M., Pole, J. C. M., Langdon, S. P., Edwards, P. A., et al. (2011) · The Journal of Pathology · doi:10.1002/path.3980 · Cited by 59
Evaluation and consequences of heterogeneity in the circulating tumor cell compartment
Brouwer, A., Laere, B. D., Peeters, D. J. E., Peeters, M., Salgado, R., Dirix, L. Y., & Laere, S. V. (2016) · Oncotarget · doi:10.18632/oncotarget.8015 · Cited by 64
Reduced expression of the H19 long non-coding RNA inhibits pancreatic cancer metastasis
Yoshimura, H., Matsuda, Y., Yamamoto, M., Michishita, M., Takahashi, K., Sasaki, N., Ishikawa, N., Aida, J., Takubo, K., Arai, T., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0048-1 · Cited by 61
Liquid biopsy in pancreatic cancer: the beginning of a new era
Yadav, D. K., Bai, X., Yadav, R. K., Singh, A., Li, G., Ma, T., Chen, W., & Liang, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24809 · Cited by 62
Patel, S. A., Rodrigues, P., Wesolowski, L., & Vanharanta, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01127-6 · Cited by 57
Shibayama, Y., Fujimori, T., Nguyen, G., Hirose, T., Totsune, K., Ichihara, A., Kitada, K., Nakano, D., Kobori, H., Kohno, M., et al. (2015) · Scientific Reports · doi:10.1038/srep08854 · Cited by 60
Self-citationLeusink, F. K. J., van Es, R. J. J., de Bree, R., de Jong, R. J. B., van Hooff, S. R., Holstege, F. C. P., Slootweg, P. J., Brakenhoff, R. H., & Takes, R. P. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70395-9 · Cited by 60
Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer
Meric‐Bernstam, F., Akçakanat, A., Chen, H., Şahin, A. A., Tarco, E., Çarkaci, S., Adrada, B. E., Singh, G., Do, K.-A., Garces, Z. M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1507 · Cited by 60
Lee, Y., Chiang, T., Liou, J., Chen, H.-H., Wu, M., & Graham, D. Y. (2015) · Gut and Liver · doi:10.5009/gnl15091 · Cited by 60
Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study
Duell, E. J., Luján‐Barroso, L., Sala, N., McElyea, S. D., Overvad, K., Tjønneland, A. M., Olsen, A., Weiderpass, E., Busund, L., Moi, L. L. H., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30790 · Cited by 60
Casey, L., & Singh, N. (2019) · Histopathology · doi:10.1111/his.13985 · Cited by 60
Wang, Q., Yan, H., Jin, Y., Wang, Z., Huang, W., Qiu, J., Kang, F., Wang, K., Zhao, X., & Tian, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.048 · Cited by 59
Jacob, L. S., Vanharanta, S., Obenauf, A. C., Pirun, M., Viale, A. J., Socci, N. D., & Massagué, J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0562 · Cited by 59
Strategies for discovering novel pancreatic cancer biomarkers
Chan, A., Diamandis, E. P., & Blasutig, I. M. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.09.025 · Cited by 61
Loveček, M., Skalický, P., Chudáček, J., Szkorupa, M., Švébišová, H., Lemstrová, R., Ehrmann, J., Melichar, B., Yogeswara, T., Klos, D., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i35.6420 · Cited by 59
Yamao, K., Takenaka, M., Ishikawa, R., Okamoto, A., Yamazaki, T., Nakai, A., Omoto, S., Kamata, K., Minaga, K., Matsumoto, I., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10070445 · Cited by 58
Pulmonary metastases in pancreatic cancer, is there a survival influence?
Deeb, A., Haque, S., & Olowokure, O. O. (2015) · PubMed Central · doi:10.3978/j.issn.2078-6891.2014.114 · Cited by 58
Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s365416 · Cited by 58
Cyclooxygenase- and lipoxygenase-mediated DNA damage
Speed, N., & Blair, I. A. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9298-8 · Cited by 58
Practicing Pathology in the Era of Big Data and Personalized Medicine
Gu, J., & Taylor, C. R. (2013) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000022 · Cited by 58
Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
Ottenhof, N. A., de Wilde, R. F., Maitra, A., Hruban, R. H., & Offerhaus, G. J. A. (2011) · Pathology Research International · doi:10.4061/2011/620601 · Cited by 62
Self-citationMakawita, S., Dimitromanolakis, A., Soosaipillai, A. R., Soleas, I. M., Chan, A., Gallinger, S., Haun, R. S., Blasutig, I. M., & Diamandis, E. P. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-404 · Cited by 58
Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology
Chiba, T., Iwama, A., & Yokosuka, O. (2015) · Hepatology Research · doi:10.1111/hepr.12548 · Cited by 58
Xie, D., Cui, J., Xia, T., Jia, Z., Wang, L., Wei, W.-F., Zhu, A., Gao, Y., Xie, K., & Quan, M. (2015) · Oncotarget · doi:10.18632/oncotarget.5772 · Cited by 58
Liu, X., Li, C., Li, J., Yu, T., Zhou, G., Cheng, J., Li, G., Zhou, Y., Lou, W., Wang, X., et al. (2018) · Journal of Cancer · doi:10.7150/jca.23989 · Cited by 58
Concepts in solid tumor evolution
Sidow, A., & Spies, N. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.02.001 · Cited by 60
Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer
Gu, X., & Minko, T. (2024) · Cancers · doi:10.3390/cancers16081589 · Cited by 60
Positive lymph nodes do not metastasize
Engel, J., Emeny, R. T., & Hölzel, D. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9343-7 · Cited by 57
Molecular Pathogenesis of Pancreatic Cancer and Clinical Perspectives
Matthaios, D., Zarogoulidis, P., Balgkouranidou, I., Chatzaki, Ε., & Kakolyris, S. (2011) · Oncology · doi:10.1159/000334449 · Cited by 60
Metadata
- Authors
- Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., & Iacobuzio-Donahue, C. A.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Harvard University (US)
- ORCID
- Venue
- Nature
- Published
- 2010-10
- Volume
- 467
- Issue
- 7319
- Pages
- 1114-1117
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3148940
- OpenAlex
- W2169895148
- Cited by
- 2,502
- References
- 24
- Citations by year
- 2026: 73 · 2025: 84 · 2024: 76 · 2023: 105 · 2022: 122 · 2021: 165 · 2020: 157 · 2019: 147 · 2018: 176 · 2017: 218 · 2016: 208 · 2015: 237 · 2014: 224 · 2013: 182 · 2012: 197
- FWCI
- 50.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (5r01ca121113-15)
- U.S. Public Health Service (A62924)
- National Cancer Institute (R01CA140599, CA 57345, R01-CA121113, CA-121113, CA43460, K08CA106610, R37CA043460, R01CA057345, CA106610, P50CA062924, R37CA057345)
- National Institute of General Medical Sciences (R01GM078986, GM078986)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pancreatic cancer, distant metastasis, clonal evolution, tumor subclones, chromosomal rearrangements, genomic instability, early detection, tumor heterogeneity, therapeutic target
- MeSH terms
- Adenocarcinoma, Autopsy, Clone Cells, DNA Mutational Analysis, Humans, Liver Neoplasms, Lung Neoplasms, Models, Biological, Mutation, Neoplasm Metastasis, Pancreas, Pancreatic Neoplasms, Peritoneal Neoplasms, Time Factors, Disease Progression, Cell Lineage, Evolution, Molecular, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
